Zobrazeno 1 - 10
of 16
pro vyhledávání: '"A E, Izu"'
Publikováno v:
Anti-Infective Applications of Interferon-Gamma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f81c72f0e1576d4dd9609e6bdec1e748
https://doi.org/10.1201/9781003066903-2
https://doi.org/10.1201/9781003066903-2
Autor:
L. R. Bucalo, Lynda C. Schneider, Henry Milgrom, Howard S. Jaffe, D. Newell, Allen E. Izu, Donald Y.M. Leung, N. Kelly, Mark Boguniewicz, P. Tam
Publikováno v:
Clinical Experimental Allergy. 23:785-790
We have recently reported that treatment of patients with severe atopic dermatitis with recombinant interferon-gamma (rIFN-gamma) resulted in clinical improvement as well as a reduction of circulating eosinophils. Since IgE-dependent late phase aller
Autor:
Graciela Cantu-Gonzales, Mark Boguniewicz, Lynda C. Schneider, Susan J. Tofte, Jon M. Hanifin, Donald Y.M. Leung, Sue E. Hirabayashi, Henry Milgrom, Kevin D. Cooper, Charles N. Ellis, Howard S. Jaffe, Allen E. Izu, Louis R. Bucalo
Publikováno v:
Journal of the American Academy of Dermatology. 28:189-197
Atopic dermatitis is characterized by immunologic abnormalities including evidence for reduced interferon gamma production. Therapeutic options for treatment of atopic dermatitis are limited and unsatisfactory. Previous open trials have suggested eff
Autor:
William G. Cheadle, Jorge L. Rodriguez, Gerald Sonnenfeld, Howard S. Jaffe, Allen E. Izu, Karen Starko, Hiram C. Polk, David H. Livingston
Publikováno v:
The American Journal of Surgery. 163:191-196
Many aspects of the normal immune response are depressed after severe injury. Reduced monocyte human leukocyte antigen-DR (HLA-DR) levels have closely correlated with the development of major infection. After a pilot study with recombinant interferon
Autor:
L M Bouvier, T L Hodges, J Mordenti, James O. Kahn, A J Amman, C J Arri, Jerome E. Groopman, A E Izu, Lawrence D. Kaplan, Paul A. Volberding
Publikováno v:
Antimicrobial Agents and Chemotherapy. 35:2580-2586
The safety and pharmacokinetics of recombinant CD4-immunoglobulin G (rCD4-IgG) were evaluated in a phase 1 study with dose escalation. A total of 16 patients, 6 with AIDS and 10 with AIDS-related complex, were evaluated at two university-affiliated h
Publikováno v:
Journal of endodontics. 30(2)
The aim of this study was to analyze the effectiveness of 5.25% sodium hypochlorite (NaOCl) in preventing inoculation of periapical tissues with contaminated patency files. Twenty-eight extracted human permanent teeth with single canals were used in
Autor:
E P, Rothstein, E L, Anderson, M D, Decker, G A, Poland, K S, Reisinger, M M, Blatter, R M, Jacobson, C A, Mink, D, Gennevois, A E, Izu, F, Sinangil, A G, Langenberg
Publikováno v:
Vaccine. 17(23-24)
Recent data indicate that Bordetella pertussis can be an important cause of illness in adolescents and adults. In a randomized observer- and subject-blinded study, adults (or = 18 years of age) received an acellular pertussis (aP) vaccine containing
Autor:
L, Corey, A G, Langenberg, R, Ashley, R E, Sekulovich, A E, Izu, J M, Douglas, H H, Handsfield, T, Warren, L, Marr, S, Tyring, R, DiCarlo, A A, Adimora, P, Leone, C L, Dekker, R L, Burke, W P, Leong, S E, Straus
Publikováno v:
JAMA. 282(4)
In the last 3 decades, herpes simplex virus type 2 (HSV-2) infection seroprevalence and neonatal herpes have increased substantially. An effective vaccine for the prevention of genital herpes could help control this epidemic.To evaluate the efficacy
Recombinant gamma interferon in treatment of patients with atopic dermatitis and elevated IgE levels
Autor:
Raif S. Geha, M. Boguniewicz, Howard S. Jaffe, Allen E. Izu, Donald Y.M. Leung, David York, Mary Jean Sullivan
Publikováno v:
The American journal of medicine. 88(4)
Recombinant gamma interferon (rIFN-gamma) inhibits IgE synthesis in vitro by human peripheral blood mononuclear cells (PBMC). These data suggest a role for rIFN-gamma in the treatment of patients with severe atopic dermatitis (AD) and elevated IgE le
Autor:
Henry Milgrom, Kevin D. Cooper, Howard S. Jaffe, Allen E. Izu, L. R. Bucalo, Lynda C. Schneider, D.Y. Leung, Mark Boguniewicz, Jon M. Hanifin
Publikováno v:
Journal of Allergy and Clinical Immunology. 87:235